Journal for ImmunoTherapy of Cancer (Nov 2020)
662 Statistical learning from clinical and immunogenomic variables to predict response and survival with PD-L1 inhibition in advanced urothelial cancer
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2020)